EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Neural correlates of Parkinson’s improvements after combined digital-levodopa therapy: a pilot study

Merav Catalogna, Nira Saporta, Tal Tamir, Shira Molcho, Rotem Sivan Hoffmann, Yasmin De Picciotto, Shai Erlich, Sheila Oren, Shahar Shelly, Amir Amedi

Brain Communications · 2026-05-05 · 8 (3)

DOI: 10.1093/braincomms/fcag148 ↗

At a glance

Journal article in Brain Communications, published online on 2026-05-20. Written by Merav Catalogna and 9 co-authors. Institution: The Dina Recanati School of Medicine, Reichman University, Herzliya 4610101, Israel. Cited 1 times so far (Crossref); 105 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Union, Horizon 2020, European Research Council.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Parkinson’s disease is characterized by progressive degeneration of dopaminergic neurons within the nigrostriatal pathway, leading to motor and non-motor deficits that become less responsive to chronic dopaminergic pharmacotherapy. Here, we examined whether a multimodal mobile digital intervention, DopApp™, delivering adaptive daily training across sensorimotor, psychological and rehabilitation domains, can induce functional reorganization of thalamocortical motor and limbic networks and augment dopaminergic treatment effects in Parkinson’s disease. To test this hypothesis, we conducted a pilot study in 42 levodopa-treated patients randomized to a 3-week DopApp™ or placebo app intervention. Clinical, psychological and resting-state functional MRI assessments were acquired at baseline and post-treatment. Compared with the placebo group, the active group showed greater motor improvements, as assessed by total scores on the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS; P < 0.001; d = 1.22). These improvements were driven by gains in motor function (Part III: P < 0.001; d = 1.16) and activities of daily living (Part II: P < 0.05; d = 0.68). Depressive symptoms also improved during the intervention (Beck’s Depression Inventory II: P < 0.05; d = 0.76), representing a parallel non-motor gain. Seed-based resting-state analyses revealed increased group-by-time connectivity within two parallel thalamocortical pathways. In the motor pathway, connectivity strengthened between the bilateral ventral lateral thalamic nuclei and primary motor cortex (PFDR < 0.05), correlating with motor improvement (MDS-UPDRS Part III: r = −0.72; P < 0.05). In parallel, increased connectivity was observed within the limbic circuit linking the anteroventral thalamus with medial prefrontal, posterior cingulate and hippocampal regions (PFDR < 0.05). Connectivity increases within this pathway correlated with improved depressive symptoms (r = −0.65; P < 0.01) and self-perceived daily function (MDS-UPDRS Part II: r = −0.66; P < 0.01). Additionally, engagement with specific app modules predicted domain-specific gains, and connectivity changes correlated with these improvements, suggesting a dose–response relationship and parallel circuit-specific neuroplasticity. These findings provide preliminary evidence supporting the integration of scalable digital interventions into precision, drug-digital treatment paradigms for Parkinson’s disease and related neurodegenerative disorders. Moreover, they represent a conceptual advance towards personalized care models that enhance drug efficacy and expand therapeutic impact beyond conventional clinical settings.

Subjects

Author keywords

Parkinson’s diseasedigital therapynon-motor symptomsresting-state fMRIthalamic nuclei

Authors and institutions

  • The Dina Recanati School of Medicine, Reichman University, Herzliya 4610101, Israel.
  • The Baruch Ivcher Institute for Brain, Cognition, and Technology, Baruch Ivcher School of Psychology, Reichman University, Herzliya 4610101, Israel.
  • Remepy Health Ltd, Scientific Department, Ramat Gan 5252247, Israel.
  • Radiology Department, Meir Medical Center, Kfar Sava 4428164, Israel.
  • Department of Neurology, Rambam Medical Center, Haifa 3109601, Israel.
  • Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Funding

  • European Union
  • Horizon 2020
  • European Research Council

Cite

APA

Catalogna, M., Saporta, N., Tamir, T., Molcho, S., Sivan Hoffmann, R., De Picciotto, Y., Erlich, S., Oren, S., Shelly, S., & Amedi, A. (2026). Neural correlates of Parkinson’s improvements after combined digital-levodopa therapy: a pilot study. Brain Communications, 8(3). https://doi.org/10.1093/braincomms/fcag148

Vancouver

Catalogna M, Saporta N, Tamir T, Molcho S, Sivan Hoffmann R, De Picciotto Y, et al. Neural correlates of Parkinson’s improvements after combined digital-levodopa therapy: a pilot study. Brain Communications. 2026;8(3). doi:10.1093/braincomms/fcag148

BibTeX
@article{Catalogna2026,
  author = {Catalogna, Merav and Saporta, Nira and Tamir, Tal and Molcho, Shira and Sivan Hoffmann, Rotem and De Picciotto, Yasmin and Erlich, Shai and Oren, Sheila and Shelly, Shahar and Amedi, Amir},
  title = {Neural correlates of Parkinson’s improvements after combined digital-levodopa therapy: a pilot study},
  journal = {Brain Communications},
  year = {2026},
  volume = {8},
  number = {3},
  doi = {10.1093/braincomms/fcag148}
}
Start for free →